메뉴 건너뛰기




Volumn 51, Issue 5, 2007, Pages 507-517

Plasma levels of unactivated thrombin activatable fibrinolysis inhibitor (TAFI) are down-regulated in young adult women: Analysis of a normal Japanese population

Author keywords

Enzyme linked immunosorbent assay (ELISA); Polymorphism; Pro carboxypeptidase R (proCPR); Thrombin activatable fibrinolysis inhibitor (TAFI)

Indexed keywords

ALANINE; ENZYME PRECURSOR; ISOLEUCINE; THREONINE; THROMBIN ACTIVATABLE FIBRINOLYSIS INHIBITOR;

EID: 34249069829     PISSN: 03855600     EISSN: 13480421     Source Type: Journal    
DOI: 10.1111/j.1348-0421.2007.tb03939.x     Document Type: Article
Times cited : (2)

References (42)
  • 2
    • 0029044322 scopus 로고
    • Purification and characterization of TAFI, a thrombin-activable fibrinolysis inhibitor
    • Bajzar, L., Manuel, R., and Nesheim, M.E. 1995. Purification and characterization of TAFI, a thrombin-activable fibrinolysis inhibitor. J. Biol. Chem. 270: 14477-14484.
    • (1995) J. Biol. Chem , vol.270 , pp. 14477-14484
    • Bajzar, L.1    Manuel, R.2    Nesheim, M.E.3
  • 3
    • 0029895009 scopus 로고    scopus 로고
    • TAFI, or plasma procarboxypeptidase B, couples the coagulation and fibrinolytic cascades through the thrombin-thrombomodulin complex
    • Bajzar, L., Morser, J., and Nesheim, M. 1996. TAFI, or plasma procarboxypeptidase B, couples the coagulation and fibrinolytic cascades through the thrombin-thrombomodulin complex. J. Biol. Chem. 271: 16603-16608.
    • (1996) J. Biol. Chem , vol.271 , pp. 16603-16608
    • Bajzar, L.1    Morser, J.2    Nesheim, M.3
  • 4
    • 0018889762 scopus 로고
    • Structure-activity relationships of vasoactive peptides derived from fibrin or fibrinogen degraded by plasmin
    • Belew, M., Gerdin, B., Lindeberg, G., Porath, J., Saldeen, T., and Wallin, R. 1980. Structure-activity relationships of vasoactive peptides derived from fibrin or fibrinogen degraded by plasmin. Biochim. Biophys. Acta 621: 169-178.
    • (1980) Biochim. Biophys. Acta , vol.621 , pp. 169-178
    • Belew, M.1    Gerdin, B.2    Lindeberg, G.3    Porath, J.4    Saldeen, T.5    Wallin, R.6
  • 5
    • 0037067719 scopus 로고    scopus 로고
    • A role for CCAAT/enhancer-binding protein in hepatic expression of thrombin-activable fibrinolysis inhibitor
    • Boffa, M.B., Hamill, J.D., Bastajian, N., Dillon, R., Nesheim, M.E., and Koschinsky, M.L. 2002. A role for CCAAT/enhancer-binding protein in hepatic expression of thrombin-activable fibrinolysis inhibitor. J. Biol. Chem. 277: 25329-25336.
    • (2002) J. Biol. Chem , vol.277 , pp. 25329-25336
    • Boffa, M.B.1    Hamill, J.D.2    Bastajian, N.3    Dillon, R.4    Nesheim, M.E.5    Koschinsky, M.L.6
  • 6
    • 0038660605 scopus 로고    scopus 로고
    • Acute phase mediators modulate thrombin-activable fibrinolysis inhibitor (TAFI) gene expression in HepG2 cells
    • Boffa, M.B., Hamill, J.D., Maret, D., Brown, D., Scott, M.L., Nesheim, M.E., and Koschinsky, M.L. 2003. Acute phase mediators modulate thrombin-activable fibrinolysis inhibitor (TAFI) gene expression in HepG2 cells. J. Biol. Chem. 278: 9250-9257.
    • (2003) J. Biol. Chem , vol.278 , pp. 9250-9257
    • Boffa, M.B.1    Hamill, J.D.2    Maret, D.3    Brown, D.4    Scott, M.L.5    Nesheim, M.E.6    Koschinsky, M.L.7
  • 7
    • 0014900566 scopus 로고
    • Anaphylatoxin inactivator of human plasma: Its isolation and characterization as a carboxypeptidase
    • Bokisch, V.A., and Muller-Eberhard, H.J. 1970. Anaphylatoxin inactivator of human plasma: its isolation and characterization as a carboxypeptidase. J. Clin. Invest. 49: 2427-2436.
    • (1970) J. Clin. Invest , vol.49 , pp. 2427-2436
    • Bokisch, V.A.1    Muller-Eberhard, H.J.2
  • 8
    • 0035885942 scopus 로고    scopus 로고
    • A novel, possibly functional, single nucleotide polymorphism in the coding region of the thrombin-activatable fibrinolysis inhibitor (TAFI) gene is also associated with TAFI levels
    • Brouwers, G.J., Vos, H.L., Leebeek, F.W., Bulk, S., Schneider, M., Boffa, M., Koschinsky, M., van Tilburg, N.H., Nesheim, M.E., Bertina, R.M., and Gomez Garcia, E.B. 2001. A novel, possibly functional, single nucleotide polymorphism in the coding region of the thrombin-activatable fibrinolysis inhibitor (TAFI) gene is also associated with TAFI levels. Blood 98: 1992-1993.
    • (2001) Blood , vol.98 , pp. 1992-1993
    • Brouwers, G.J.1    Vos, H.L.2    Leebeek, F.W.3    Bulk, S.4    Schneider, M.5    Boffa, M.6    Koschinsky, M.7    van Tilburg, N.H.8    Nesheim, M.E.9    Bertina, R.M.10    Gomez Garcia, E.B.11
  • 9
    • 0024412863 scopus 로고
    • An arginine specific carboxypeptidase generated in blood during coagulation or inflammation which is unrelated to carboxypeptidase N or its subunits
    • Campbell, W., and Okada, H. 1989. An arginine specific carboxypeptidase generated in blood during coagulation or inflammation which is unrelated to carboxypeptidase N or its subunits. Biochem. Biophys. Res. Commun. 162: 933-939.
    • (1989) Biochem. Biophys. Res. Commun , vol.162 , pp. 933-939
    • Campbell, W.1    Okada, H.2
  • 10
    • 0025309851 scopus 로고
    • An arginine carboxypeptidase generated during coagulation is diminished or absent in patients with rheumatoid arthritis
    • Campbell, W., Yonezu, K., Shinohara, T., and Okada, H. 1990. An arginine carboxypeptidase generated during coagulation is diminished or absent in patients with rheumatoid arthritis. J. Lab. Clin. Med. 115: 610-612.
    • (1990) J. Lab. Clin. Med , vol.115 , pp. 610-612
    • Campbell, W.1    Yonezu, K.2    Shinohara, T.3    Okada, H.4
  • 11
    • 0036191244 scopus 로고    scopus 로고
    • Inactivation of C3a and C5a octapeptides by carboxypeptidase R and carboxypeptidase N
    • Campbell, W.D., Lazoura, E., Okada, N., and Okada, H. 2002. Inactivation of C3a and C5a octapeptides by carboxypeptidase R and carboxypeptidase N. Microbiol. Immunol. 46: 131-134.
    • (2002) Microbiol. Immunol , vol.46 , pp. 131-134
    • Campbell, W.D.1    Lazoura, E.2    Okada, N.3    Okada, H.4
  • 13
    • 17444368310 scopus 로고    scopus 로고
    • Short-term effects of estrogen, tamoxifen and raloxifene on hemostasis: A randomized-controlled study and review of the literature
    • Cosman, F., Baz-Hecht, M., Cushman, M., Vardy, M.D., Cruz, J.D., Nieves, J.W., Zion, M., and Lindsay, R. 2005. Short-term effects of estrogen, tamoxifen and raloxifene on hemostasis: a randomized-controlled study and review of the literature. Thromb. Res. 116: 1-13.
    • (2005) Thromb. Res , vol.116 , pp. 1-13
    • Cosman, F.1    Baz-Hecht, M.2    Cushman, M.3    Vardy, M.D.4    Cruz, J.D.5    Nieves, J.W.6    Zion, M.7    Lindsay, R.8
  • 14
    • 0025748556 scopus 로고
    • Isolation, molecular cloning, and partial characterization of a novel carboxypeptidase B from human plasma
    • Eaton, D.L., Malloy, B.E., Tsai, S.P., Henzel, W., and Drayna, D. 1991. Isolation, molecular cloning, and partial characterization of a novel carboxypeptidase B from human plasma. J. Biol. Chem. 266: 21833-21838.
    • (1991) J. Biol. Chem , vol.266 , pp. 21833-21838
    • Eaton, D.L.1    Malloy, B.E.2    Tsai, S.P.3    Henzel, W.4    Drayna, D.5
  • 15
    • 0000077897 scopus 로고
    • An enzyme in human blood plasma that inactivates bradykinin and kallidins
    • Erdos, E.G., and Sloane, E.M. 1962. An enzyme in human blood plasma that inactivates bradykinin and kallidins. Biochem. Pharmacol. 11: 585-592.
    • (1962) Biochem. Pharmacol , vol.11 , pp. 585-592
    • Erdos, E.G.1    Sloane, E.M.2
  • 17
    • 1542269664 scopus 로고    scopus 로고
    • Association between thrombin activatable fibrinolysis inhibitor genotype and levels in plasma: Comparison of different assays
    • Guimaraes, A.H., van Tilburg, N.H., Vos, H.L., Bertina, R.M., and Rijken, D.C. 2004. Association between thrombin activatable fibrinolysis inhibitor genotype and levels in plasma: comparison of different assays. Br. J. Haematol. 124: 659-665.
    • (2004) Br. J. Haematol , vol.124 , pp. 659-665
    • Guimaraes, A.H.1    van Tilburg, N.H.2    Vos, H.L.3    Bertina, R.M.4    Rijken, D.C.5
  • 18
    • 84945736607 scopus 로고
    • Characterisation of a carboxypeptidase in human serum distinct from carboxypeptidase N
    • Hendriks, D., Scharpe, S., van Sande, M., and Lommaert, M.P. 1989. Characterisation of a carboxypeptidase in human serum distinct from carboxypeptidase N. J. Clin. Chem. Clin. Biochem. 27: 277-285.
    • (1989) J. Clin. Chem. Clin. Biochem , vol.27 , pp. 277-285
    • Hendriks, D.1    Scharpe, S.2    van Sande, M.3    Lommaert, M.P.4
  • 19
    • 0025255189 scopus 로고
    • Purification and characterization of a new arginine carboxypeptidase in human serum
    • Hendriks, D., Wang, W., Scharpe, S., Lommaert, M.P., and van Sande, M. 1990. Purification and characterization of a new arginine carboxypeptidase in human serum. Biochim. Biophys. Acta 1034: 86-92.
    • (1990) Biochim. Biophys. Acta , vol.1034 , pp. 86-92
    • Hendriks, D.1    Wang, W.2    Scharpe, S.3    Lommaert, M.P.4    van Sande, M.5
  • 20
    • 0035313252 scopus 로고    scopus 로고
    • Identification of polymorphisms in the promoter and the 3′ region of the TAFI gene: Evidence that plasma TAFI antigen levels are strongly genetically controlled
    • Henry, M., Aubert, H., Morange, P.E., Nanni, I., Alessi, M.C., Tiret, L., and Juhan-Vague, I. 2001. Identification of polymorphisms in the promoter and the 3′ region of the TAFI gene: evidence that plasma TAFI antigen levels are strongly genetically controlled. Blood 97: 2053-2058.
    • (2001) Blood , vol.97 , pp. 2053-2058
    • Henry, M.1    Aubert, H.2    Morange, P.E.3    Nanni, I.4    Alessi, M.C.5    Tiret, L.6    Juhan-Vague, I.7
  • 23
    • 0345601770 scopus 로고    scopus 로고
    • Polymorphisms in the TAFI gene and the risk of venous thrombosis
    • Kostka, H., Kuhlisch, E., Schellong, S., and Siegert, G. 2003. Polymorphisms in the TAFI gene and the risk of venous thrombosis. Clin. Lab. 49: 645-647.
    • (2003) Clin. Lab , vol.49 , pp. 645-647
    • Kostka, H.1    Kuhlisch, E.2    Schellong, S.3    Siegert, G.4
  • 24
    • 0036493728 scopus 로고    scopus 로고
    • Thr325IIe polymorphism of the TAFI gene does not influence the risk of myocardial infection
    • Morange, P.E., Henry, M., Frere, C., and Juhan-Vague, I. 2002. Thr325IIe polymorphism of the TAFI gene does not influence the risk of myocardial infection. Blood 99: 1878-1879.
    • (2002) Blood , vol.99 , pp. 1878-1879
    • Morange, P.E.1    Henry, M.2    Frere, C.3    Juhan-Vague, I.4
  • 25
    • 0038454527 scopus 로고    scopus 로고
    • Identification of thrombin activatable fibrinolysis inhibitor (TAFI) in human platelets
    • Mosnier, L.O., Buijtenhuijs, P., Marx, P.F., Meijers, J.C., and Bouma, B.N. 2003. Identification of thrombin activatable fibrinolysis inhibitor (TAFI) in human platelets. Blood 101: 4844-4846.
    • (2003) Blood , vol.101 , pp. 4844-4846
    • Mosnier, L.O.1    Buijtenhuijs, P.2    Marx, P.F.3    Meijers, J.C.4    Bouma, B.N.5
  • 26
    • 0035173479 scopus 로고    scopus 로고
    • Regulation of fibrinolysis in plasma by TAFI and protein C is dependent on the concentration of thrombomodulin
    • Mosnier, L.O., Meijers, J.C., and Bouma, B.N. 2001. Regulation of fibrinolysis in plasma by TAFI and protein C is dependent on the concentration of thrombomodulin. Thromb. Haemost. 85: 5-11.
    • (2001) Thromb. Haemost , vol.85 , pp. 5-11
    • Mosnier, L.O.1    Meijers, J.C.2    Bouma, B.N.3
  • 28
    • 0036119128 scopus 로고    scopus 로고
    • Oral oestradiol/trimegestone replacement reduces procarboxypeptidase U (TAFI): A randomized, placebo-controlled, 12-week study in early postmenopausal women
    • Post, M.S., Hendriks, D.F., Van Der Mooren, M.J., Van Baal, W.M., Leurs, J.R., Emeis, J.J., Kenemans, P., and Stehouwer, C.D. 2002. Oral oestradiol/trimegestone replacement reduces procarboxypeptidase U (TAFI): a randomized, placebo-controlled, 12-week study in early postmenopausal women. J. Intern. Med. 251: 245-251.
    • (2002) J. Intern. Med , vol.251 , pp. 245-251
    • Post, M.S.1    Hendriks, D.F.2    Van Der Mooren, M.J.3    Van Baal, W.M.4    Leurs, J.R.5    Emeis, J.J.6    Kenemans, P.7    Stehouwer, C.D.8
  • 30
    • 3242780163 scopus 로고    scopus 로고
    • Risk of acute coronary artery disease associated with functional thrombin activatable fibrinolysis inhibitor plasma level
    • Santamaria, A., Martinez-Rubio, A., Borrell, M., Mateo, J., Ortin, R., and Fontcuberta, J. 2004. Risk of acute coronary artery disease associated with functional thrombin activatable fibrinolysis inhibitor plasma level. Haematologica 89: 880-881.
    • (2004) Haematologica , vol.89 , pp. 880-881
    • Santamaria, A.1    Martinez-Rubio, A.2    Borrell, M.3    Mateo, J.4    Ortin, R.5    Fontcuberta, J.6
  • 31
    • 0034661975 scopus 로고    scopus 로고
    • Pro-carboxypeptidase R is an acute phase protein in the mouse, whereas carboxypeptidase N is not
    • Sato, T., Miwa, T., Akatsu, H., Matsukawa, N., Obata, K., Okada, N., Campbell, W., and Okada, H. 2000. Pro-carboxypeptidase R is an acute phase protein in the mouse, whereas carboxypeptidase N is not. J. Immunol. 165: 1053-1058.
    • (2000) J. Immunol , vol.165 , pp. 1053-1058
    • Sato, T.1    Miwa, T.2    Akatsu, H.3    Matsukawa, N.4    Obata, K.5    Okada, N.6    Campbell, W.7    Okada, H.8
  • 32
    • 0037059828 scopus 로고    scopus 로고
    • Two naturally occurring variants of TAFI (Thr-325 and Ile-325) differ substantially with respect to thermal stability and antifibrinolytic activity of the enzyme
    • Schneider, M., Boffa, M., Stewart, R., Rahman, M., Koschinsky, M., and Nesheim, M. 2002. Two naturally occurring variants of TAFI (Thr-325 and Ile-325) differ substantially with respect to thermal stability and antifibrinolytic activity of the enzyme. J. Biol. Chem. 277: 1021-1030.
    • (2002) J. Biol. Chem , vol.277 , pp. 1021-1030
    • Schneider, M.1    Boffa, M.2    Stewart, R.3    Rahman, M.4    Koschinsky, M.5    Nesheim, M.6
  • 33
    • 12244252240 scopus 로고    scopus 로고
    • Thrombin activatable fibrinolysis inhibitor (TAFI) levels in patients with coronary artery disease investigated by angiography
    • Schroeder, V., Chatterjee, T., Mehta, H., Windecker, S., Pham, T., Devantay, N., Meier, B., and Kohler, H.P. 2002. Thrombin activatable fibrinolysis inhibitor (TAFI) levels in patients with coronary artery disease investigated by angiography. Thromb. Haemost. 88: 1020-1025.
    • (2002) Thromb. Haemost , vol.88 , pp. 1020-1025
    • Schroeder, V.1    Chatterjee, T.2    Mehta, H.3    Windecker, S.4    Pham, T.5    Devantay, N.6    Meier, B.7    Kohler, H.P.8
  • 36
    • 0037263617 scopus 로고    scopus 로고
    • Preferential detection of pro-carboxypeptidase R by enzyme-linked immunosorbent assay
    • Tani, S., Akatsu, H., Ishikawa, Y., Okada, N., and Okada, H. 2003. Preferential detection of pro-carboxypeptidase R by enzyme-linked immunosorbent assay. Microbiol. Immunol. 47: 295-300.
    • (2003) Microbiol. Immunol , vol.47 , pp. 295-300
    • Tani, S.1    Akatsu, H.2    Ishikawa, Y.3    Okada, N.4    Okada, H.5
  • 37
    • 0014375828 scopus 로고
    • Degradation of human fibrinopeptides A and B in blood serum in vitro
    • Teger-Nilsson, A.C. 1968. Degradation of human fibrinopeptides A and B in blood serum in vitro. Acta Chem. Scand. 22: 3171-3182.
    • (1968) Acta Chem. Scand , vol.22 , pp. 3171-3182
    • Teger-Nilsson, A.C.1
  • 38
    • 0034839296 scopus 로고    scopus 로고
    • Combined segregation-linkage analysis of plasma thrombin activatable fibrinolysis inhibitor (TAFI) antigen levels with TAFI gene polymorphisms
    • Tregouet, D.A., Aubert, H., Henry, M., Morange, P., Visvikis, S., Juhan-Vague, I., and Tiret, L. 2001. Combined segregation-linkage analysis of plasma thrombin activatable fibrinolysis inhibitor (TAFI) antigen levels with TAFI gene polymorphisms. Hum. Genet. 109: 191-197.
    • (2001) Hum. Genet , vol.109 , pp. 191-197
    • Tregouet, D.A.1    Aubert, H.2    Henry, M.3    Morange, P.4    Visvikis, S.5    Juhan-Vague, I.6    Tiret, L.7
  • 39
    • 0034192129 scopus 로고    scopus 로고
    • Thrombin activatable fibrinolysis inhibitor and the risk for deep vein thrombosis
    • van Tilburg, N.H., Rosendaal, F.R., and Bertina, R.M. 2000. Thrombin activatable fibrinolysis inhibitor and the risk for deep vein thrombosis. Blood 95: 2855-2859.
    • (2000) Blood , vol.95 , pp. 2855-2859
    • van Tilburg, N.H.1    Rosendaal, F.R.2    Bertina, R.M.3
  • 40
    • 0035479232 scopus 로고    scopus 로고
    • Activity and antigen levels of thrombin-activatable fibrinolysis inhibitor in plasma of patients with disseminated intravascular coagulation
    • Watanabe, R., Wada, H., Watanabe, Y., Sakakura, M., Nakasaki, T., Mori, Y., Nishikawa, M., Gabazza, E.C., Nobori, T., and Shiku, H. 2001. Activity and antigen levels of thrombin-activatable fibrinolysis inhibitor in plasma of patients with disseminated intravascular coagulation. Thromb. Res. 104: 1-6.
    • (2001) Thromb. Res , vol.104 , pp. 1-6
    • Watanabe, R.1    Wada, H.2    Watanabe, Y.3    Sakakura, M.4    Nakasaki, T.5    Mori, Y.6    Nishikawa, M.7    Gabazza, E.C.8    Nobori, T.9    Shiku, H.10
  • 41
    • 0031766583 scopus 로고    scopus 로고
    • Identification and characterization of two thrombin-activatable fibrinolysis inhibitor isoforms
    • Zhao, L., Morser, J., Bajzar, L., Nesheim, M., and Nagashima, M. 1998. Identification and characterization of two thrombin-activatable fibrinolysis inhibitor isoforms. Thromb. Haemost. 80: 949-955.
    • (1998) Thromb. Haemost , vol.80 , pp. 949-955
    • Zhao, L.1    Morser, J.2    Bajzar, L.3    Nesheim, M.4    Nagashima, M.5
  • 42
    • 0141540528 scopus 로고    scopus 로고
    • Thrombinactivatable fibrinolysis inhibitor in young patients with myocardial infarction and its relationship with the fibrinolytic function and the protein C system
    • Zorio, E., Castello, R., Falco, C., Espana, F., Osa, A., Almenar, L., Aznar, J., and Estelles, A. 2003. Thrombinactivatable fibrinolysis inhibitor in young patients with myocardial infarction and its relationship with the fibrinolytic function and the protein C system. Br. J. Haematol. 122: 958-965.
    • (2003) Br. J. Haematol , vol.122 , pp. 958-965
    • Zorio, E.1    Castello, R.2    Falco, C.3    Espana, F.4    Osa, A.5    Almenar, L.6    Aznar, J.7    Estelles, A.8


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.